| pubmed-article:8200003 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8200003 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:8200003 | lifeskim:mentions | umls-concept:C0278996 | lld:lifeskim |
| pubmed-article:8200003 | lifeskim:mentions | umls-concept:C0032743 | lld:lifeskim |
| pubmed-article:8200003 | lifeskim:mentions | umls-concept:C1524063 | lld:lifeskim |
| pubmed-article:8200003 | lifeskim:mentions | umls-concept:C0872172 | lld:lifeskim |
| pubmed-article:8200003 | pubmed:issue | 12 | lld:pubmed |
| pubmed-article:8200003 | pubmed:dateCreated | 1994-7-7 | lld:pubmed |
| pubmed-article:8200003 | pubmed:abstractText | The purpose of this study was to evaluate the utility of positron emission tomography- (PET) 2-[18F]-fluoro-2-deoxy-D-glucose (FDG) imaging in extracranial head and neck cancers. | lld:pubmed |
| pubmed-article:8200003 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8200003 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8200003 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:8200003 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8200003 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8200003 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8200003 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:8200003 | pubmed:issn | 0008-543X | lld:pubmed |
| pubmed-article:8200003 | pubmed:author | pubmed-author:PhelpsM EME | lld:pubmed |
| pubmed-article:8200003 | pubmed:author | pubmed-author:MaddahiJJ | lld:pubmed |
| pubmed-article:8200003 | pubmed:author | pubmed-author:AnzaiYY | lld:pubmed |
| pubmed-article:8200003 | pubmed:author | pubmed-author:ChoiYY | lld:pubmed |
| pubmed-article:8200003 | pubmed:author | pubmed-author:JuillardGG | lld:pubmed |
| pubmed-article:8200003 | pubmed:author | pubmed-author:GohB MBM | lld:pubmed |
| pubmed-article:8200003 | pubmed:author | pubmed-author:RegeSS | lld:pubmed |
| pubmed-article:8200003 | pubmed:author | pubmed-author:LufkinRR | lld:pubmed |
| pubmed-article:8200003 | pubmed:author | pubmed-author:MaassAA | lld:pubmed |
| pubmed-article:8200003 | pubmed:author | pubmed-author:ChaikenLL | lld:pubmed |
| pubmed-article:8200003 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8200003 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:8200003 | pubmed:volume | 73 | lld:pubmed |
| pubmed-article:8200003 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8200003 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8200003 | pubmed:pagination | 3047-58 | lld:pubmed |
| pubmed-article:8200003 | pubmed:dateRevised | 2010-3-24 | lld:pubmed |
| pubmed-article:8200003 | pubmed:meshHeading | pubmed-meshheading:8200003-... | lld:pubmed |
| pubmed-article:8200003 | pubmed:meshHeading | pubmed-meshheading:8200003-... | lld:pubmed |
| pubmed-article:8200003 | pubmed:meshHeading | pubmed-meshheading:8200003-... | lld:pubmed |
| pubmed-article:8200003 | pubmed:meshHeading | pubmed-meshheading:8200003-... | lld:pubmed |
| pubmed-article:8200003 | pubmed:meshHeading | pubmed-meshheading:8200003-... | lld:pubmed |
| pubmed-article:8200003 | pubmed:meshHeading | pubmed-meshheading:8200003-... | lld:pubmed |
| pubmed-article:8200003 | pubmed:meshHeading | pubmed-meshheading:8200003-... | lld:pubmed |
| pubmed-article:8200003 | pubmed:meshHeading | pubmed-meshheading:8200003-... | lld:pubmed |
| pubmed-article:8200003 | pubmed:meshHeading | pubmed-meshheading:8200003-... | lld:pubmed |
| pubmed-article:8200003 | pubmed:meshHeading | pubmed-meshheading:8200003-... | lld:pubmed |
| pubmed-article:8200003 | pubmed:meshHeading | pubmed-meshheading:8200003-... | lld:pubmed |
| pubmed-article:8200003 | pubmed:meshHeading | pubmed-meshheading:8200003-... | lld:pubmed |
| pubmed-article:8200003 | pubmed:meshHeading | pubmed-meshheading:8200003-... | lld:pubmed |
| pubmed-article:8200003 | pubmed:year | 1994 | lld:pubmed |
| pubmed-article:8200003 | pubmed:articleTitle | Use of positron emission tomography with fluorodeoxyglucose in patients with extracranial head and neck cancers. | lld:pubmed |
| pubmed-article:8200003 | pubmed:affiliation | Department of Molecular and Medical Pharmacology, UCLA School of Medicine. | lld:pubmed |
| pubmed-article:8200003 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8200003 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8200003 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8200003 | lld:pubmed |
